HonorHealth Research Institute, City of Hope and TGen lead international team in creating ‘robust’ early-detection method for pancreatic cancer
Using a simple blood test, early detection of this silent killer — usually not diagnosed until its late stages — is key to successful treatment
2023-10-19
(Press-News.org) SCOTTSDALE, Ariz. — Oct. 18, 2023 — In a significant breakthrough that could eventually extend the survival of patients with one of the deadliest of all malignancies, an international team of researchers have devised an investigational blood test that might one day help doctors detect pancreatic cancer earlier.
The team from the U.S., China, South Korea and Japan created and tested a biomarker panel that detects small amounts of RNA genetic material that breaks off from pancreatic cancer cells and circulates in the bloodstream, known as circular RNA or circRNA, according to results of a study published in the journal Gastroenterology.
The U.S. team members include City of Hope; Translational Genomics Research Institute (TGen), part of the City of Hope; and HonorHealth Research Institute.
More than 50,500 Americans will die this year from pancreatic cancer, making it the third leading cause of cancer-related death behind lung and colon cancers. Both the number of cases and deaths due to pancreatic cancer continue to increase year after year. Only about 11% of those diagnosed with this type of cancer survive more than 5 years.
One of the primary reasons for the dismal survival rates in pancreatic cancer is that most patients are usually diagnosed in late stages when the disease has already spread to other parts of the body. Because the pancreas is deep within the abdominal cavity, this type of cancer usually does not cause pain or inflammation in its early stages, symptoms that might otherwise reveal the presence of disease. Fewer than 15% of pancreatic cancer patients are diagnosed at a stage when the cancer can be surgically removed, the study said.
‘Urgent’ need for early detection test
“These data highlight the urgent, unmet clinical need to identify and develop diagnostic methods that could precisely detect pancreatic cancer at its earliest stages, when the disease is still confined to the pancreas and surgical resection is still an option,” said Ajay Goel, Ph.D., AGAF, the study’s senior author. Dr. Goel is professor and founding chair of the Department of Molecular Diagnostics and Experimental Therapeutics at the Beckman Research Institute of City of Hope and associate director of basic science for City of Hope Comprehensive Cancer Center.
Previous diagnostic efforts using imaging and blood levels of CA 19-9, a cancer antigen, have proved inadequate and misleading. Pancreatic cancer does not always produce detectable amounts of CA 19-9 in early stages, leading to false negatives. It also is elevated in other gastrointestinal cancers and conditions.
“We hypothesized that circRNAs might offer diagnostic potential in pancreatic cancer. Recent evidence indicates that circRNAs might have untapped potential as biomarkers for cancer diagnosis and prognosis,” said Caiming Xu, M.D., Ph.D., the study’s lead author and a visiting post-doctoral fellow in Dr. Goel’s lab. Dr. Caiming also is part of the First Affiliated Hospital of Dalian (China) Medical University.
Because they form in a circle, circRNAs are more stable and have longer half-lives compared with linear RNAs, and circRNAs are abundantly expressed in the bloodstream. It has only been in recent years that genetic sequencing technology has advanced sufficiently to precisely detect, process and analyze circRNA.
Using genome-wide expression profiling, researchers undertook a systematic and comprehensive review of patient samples to discover pancreatic cancer biomarkers based on circRNA that could distinguish pancreatic cancer tumors from adjacent normal tissue specimens, especially among those patients with early-stage disease.
Blood panel had ‘robust diagnostic accuracy’
Five candidate biomarkers were used to devise a blood-based panel test — a non-invasive, liquid biopsy-based assay — for early detection of pancreatic cancer; a test that “exhibited robust diagnostic accuracy,” according to the study. The predictive performance of these biomarkers “improved remarkably” when analyzed in conjunction with CA 19-9, the study said.
Blood-based liquid biopsies have multiple advantages over tissue-based traditional biopsies, including their noninvasiveness, ease of sample collection, and accurate results, which can be exploited as an important tool in the early detection of cancers and patient disease management.
“When pancreatic cancer is caught early, the chance of survival is so much greater than when diagnosed in the advanced stage. Therefore, there is a great need to develop novel ways to detect pancreatic cancer,” said Erkut Borazanci, M.D., research director of the Cancer Research Division at HonorHealth Research Institute, and one of the study’s authors.
“By collaborating with City of Hope, TGen and other centers working together, we are making strides where we hope for a future reality in which pancreatic cancer is detected early, and that we are talking about cures for more people,” Dr. Borazanci said.
Study researchers, all part of the Pancreatic Cancer Detection Consortium, concluded that addition tests should be conducted to determine if there are any differences due to patients’ age, sex or other factors: “Although the performance seems promising, further investigation is warranted for our circRNA-based panel of biomarkers to be found eligible as a reliable clinical test.”
Nearly a decade in the making
Still, the results of this study go a long way toward achieving the goal of better cancer diagnostics, said Daniel Von Hoff, M.D., a Distinguished Professor at the Translational Genomics Research Institute (TGen), part of City of Hope, and one of the study’s authors. Dr. Von Hoff has worked for nearly a decade with Dr. Borazanci to discover a way to detect pancreatic cancer in its early stages.
“Perfecting a method of early detection for this extremely aggressive cancer would be a substantial step in providing better care for patients with pancreatic cancer,” Dr. Von Hoff said. “It could also be the basis for eventually developing early-detection tests for other cancers, as well.”
The study — A circulating panel of circRNA biomarkers for the noninvasive and early detection of pancreatic ductal adenocarcinoma — was published Oct. 13.
Other collaborators on this study included: Ochsner Clinic Foundation in New Orleans; Asan Medical Center in Seoul, South Korea; Mie University Graduate School of Medicine in Mie, Japan; and Hokkaido University in Hokkaido, Japan.
This study was funded by grants from the National Cancer Institute in the U.S., and from the National Natural Science Foundation of China.
END
ELSE PRESS RELEASES FROM THIS DATE:
2023-10-19
Scientists and natural resource managers from Canadian First Nations, governments, academic institutions, and conservation organizations published the first results of a unique salmon population monitoring tool in Frontiers in Marine Science. This groundbreaking new technology, dubbed “Salmon Vision,” combines artificial intelligence with age-old fishing weir technology. Early assessments show it to be remarkably adept at identifying and counting fish species, potentially enabling real-time salmon population monitoring for fisheries managers.
“In ...
2023-10-19
Unemployment among the youth is a serious problem in many developing countries, especially in Africa. This issue stems in great part from a stagnant manufacturing sector. Firms in African countries have failed to grow significantly over the past decade, leading to fewer job positions for the youth.
Foreign direct investment (FDI) is a promising avenue for addressing this challenge. Local firms in developing countries can learn advanced technologies and management strategies from multinational companies. This transmission of knowledge, in general, helps make ...
2023-10-19
G protein-coupled receptors (GPCRs) are the largest and most diverse group of cell surface proteins in humans. These receptors, which can be seen as ‘traffic directors,’ transmit signals from the outside to the inside of cells and are involved in many physiological processes. Given their prominent roles in cellular communication, cell growth, immune responses, and sensory perception, many drugs have been developed to target GPCRs, for the treatment of conditions such as asthma, allergies, depression, hypertension, and heart disease. In fact, more than 300 GPCR-related drugs are currently in clinical trials, 36% ...
2023-10-19
Proteins are important molecules that perform a variety of functions essential to life. To function properly, many proteins must fold into specific structures. However, the way proteins fold into specific structures is still largely unknown. Researchers from the University of Tokyo developed a novel physical theory that can accurately predict how proteins fold. Their model can predict things previous models cannot. Improved knowledge of protein folding could offer huge benefits to medical research, as well as to various industrial processes.
You are literally made of proteins. These chainlike molecules, made from tens to thousands of smaller molecules called amino acids, form things like hair, ...
2023-10-19
A McMaster University-led analysis published in the BMJ on Oct. 19, exposes high rates of injuries with forceps and vacuum delivery in Canada that have been documented for over a decade without efforts to address them.
The paper, titled Maternal and neonatal trauma during forceps and vacuum delivery must not be overlooked, was authored by perinatal epidemiologists, obstetricians, urogynecologists, community advocates and patient partners, and calls for increased recognition, transparency and action to prevent these injuries.
As part of the analysis, researchers present data from the Organisation for Economic Co-operation ...
2023-10-19
Toronto, ON — New research from the University of Toronto has revealed the mental health toll of the COVID-19 pandemic on older adults with peptic ulcer disease (PUD), a painful condition in which gastric sores develop in the lining of the stomach or upper portion of the small intestine.
The researchers examined a subsample of older adults from the Canadian Longitudinal Study on Aging, a national dataset of older Canadians. The sample consisted of 1,140 older adults with PUD, of whom 689 had a pre-pandemic history of depression and 451 had no history of depression. By using longitudinal data, the researchers were ...
2023-10-19
Key takeaways:
Eating more than one weekly serving of red meat may raise type 2 diabetes risk.
Replacing red meat with plant-based protein sources, such as nuts and legumes, may reduce risk of type 2 diabetes.
Embargoed for release: Thursday, October 19, 4:00 AM ET
Boston, MA — People who eat just two servings of red meat per week may have an increased risk of developing type 2 diabetes compared to people who eat fewer servings, and the risk increases with greater consumption, according to a new study led by researchers from Harvard T.H. ...
2023-10-19
Grouping English learners together in classrooms, a longstanding practice in schools, has no impact—positive or negative—on reading development for elementary school students, shows a new study by a team of literacy education researchers.
“When I taught middle school 20 years ago, I noticed that my English learner students were separated from their native English-speaking peers all day long,” says NYU Steinhardt associate professor Michael Kieffer, the study’s lead author. “Data show that this practice continues in many places today, ...
2023-10-19
Arlington, Va. — October 19, 2023 — A new report published today in the American Journal of Infection Control (AJIC) demonstrates that implementing a dedicated team of nurses to assist with central line insertions can reduce patients’ risk of developing bloodstream infections due to those central lines. In this report, infection preventionists at UNC Health found that having this dedicated team reduced the proportion of central line-associated bloodstream infections occurring within ...
2023-10-19
Scientists have discovered the deepest known evidence of coral reef bleaching, more than 90 metres below the surface of the Indian Ocean.
The damage – attributed to a 30% rise in sea temperatures caused by the Indian Ocean dipole – harmed up to 80% of the reefs in certain parts of the seabed, at depths previously thought to be resilient to ocean warming.
However, scientists say it serves as a stark warning of the harm caused in our ocean by rising ocean temperatures, and also of the hidden damage being caused throughout the natural world as a result of climate change.
The findings, highlighted in a study published ...
LAST 30 PRESS RELEASES:
[Press-News.org] HonorHealth Research Institute, City of Hope and TGen lead international team in creating ‘robust’ early-detection method for pancreatic cancer
Using a simple blood test, early detection of this silent killer — usually not diagnosed until its late stages — is key to successful treatment
